Glucotize is a proprietary, orally active, controlled-release formulation of alpha-lipoic acid manufactured and distributed by Medical Research Institute (MRI), San Francisco CA. Alpha-Lipoic acid is produced naturally in human cells where it functions as a coenzyme that contributes to oxidative glucose metabolism.

Glucotize Benefits

• Helps facilitate whole-body glucose utilization
• Helps reduce oxidative stress that leads to diabetic neuropathy
• Boosts levels of vitamins C, E, and CoQ10
• Increases intracellular levels of glutathione, the body's natural cell detoxifier

Glucotize Features

• Clinically-tested safe
• Well-absorbed by the stomach
• Non-toxic
• Serves as a cofactor in glucose utilization and energy production
• Potent antioxidant capable of penetrating both water-soluble and lipid-soluble membranes

Glucotize Advantage

The primary advantage of the Glucotize formulation is that it increases the length of time in plasma of alpha-lipoic acid (several hours). This provides Glucotize with a pharmacokinetic advantage that is a marked improvement over other alpha-lipoic acid products in which alpha-lipoic acid is rapidly cleared, usually within 30 minutes (2). Controlled-release technology is what makes Glucotize appropriate for use as a potent oxidative stress antagonist. Oxidative stress, and specifically its imbalance with antioxidant depletion, is associated with neuropathy.

Recommended Dosing

Take 2 tablets in the morning and 2 tablets in the evening on an empty stomach at least 30 minutes before intake of food, or as directed by your health care professional.

Contraindications

Glucotize is contraindicated in individuals with known hypersensitivity to alpha-lipoic acid or other sulfur-containing compounds. Glucotize is contraindicated in individuals that are thiamin deficient.

Interactions

There are no known drug interactions with alpha-lipoic acid.